Cadila Healthcare says US FDA closes inspection of Ahmedabad ointment plant


Cadila Healthcare said that US FDA has successfully closed an inspection at its facility at Changodar at Ahmedabad.

The inspection was carried out in March 2016. The plant makes ointments and is not part of Moraiya formulations manufacturing plant, it said.

The receipt of Establishment Inspection Report (EIR) “indicates the successful closure of the inspection points (483s) raised”.

Cadila healthcare is an Indian pharmaceutical company headquartered at Ahmedabad, Gujrat. It is a significant manufacturer of generic drugs.